Patient management roundtable

The session director and speakers of today’s symposium, “Common, Challenging, and Controversial Short Topics in Patient Management” (S011), share valuable insight into managing patients.

April Armstrong, MD, MPH, Los Angeles

Topic: Psoriasis
Common
We have more biologic agents available to treat psoriasis than ever before. The real problem is selecting the agent that is most appropriate for each patient in an evidence-based fashion.

Challenging
There are a number of promising new agents in development. As dermatologists, we have to keep abreast of what is in the pipeline.

Controversial
Psoriasis is a chronic disease. One of the most controversial aspects of treatment is understanding and evaluating how these agents will perform over the long term in our patients.

Minnelly Luu, MD, Los Angeles

Topic: Pediatric dermatology
Common
Moles are equally common in children as they are in adults, but they follow different rules. The approach that one might take with adult patients may not be appropriate for children.

Challenging
Molluscum is one of the most common viral skin infections in children. It is known to self-resolve, yet many parents come to dermatologists seeking treatment.

Controversial
Common conditions can be the most troublesome and controversial because a clear answer isn’t available in terms of how to assess and manage. Evaluating the evidence behind the different modalities currently being employed can help defuse the discussions.

Zakia Rahman, MD, Palo Alto, California

Topic: Aesthetic dermatology
Common
We now have a variety of toxins to work with and new toxins are on the horizon. Selecting the right toxin for the right patient is an everyday issue.

Challenging
We’ve been flooded with unattainable ideals of perfection. A lot of  young people are having cosmetic procedures and becoming deformed caricatures of themselves.

Controversial
There are a lot of functional issues where these laser and radio frequency devices could be of benefit, but a growing portion of the demand is not for functional issues. We have the expertise to treat safely, but it is just as important to know when not to treat.

 

Return to index

Top